Lai Wang - 11 Jun 2026 Form 4 Insider Report for BeOne Medicines Ltd. (ONC)

Reporting relationship: President, Global Head of R&D
Issuer ticker: ONC
Reported as of: 11 Jun 2026
Net transaction value: -$197,318
SEC form: 4
Accepted by SEC: 15 Jun 2026, 17:55:30 UTC
Prior SEC filing: 10 Jun 2026
Next SEC filing: 18 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Qing Nian, as Attorney-in-Fact

Key filing fact

Lai Wang filed Form 4 for BeOne Medicines Ltd. (ONC) on 15 Jun 2026.

Key facts

This page summarizes Lai Wang's Form 4 filing for BeOne Medicines Ltd. (ONC).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 15 Jun 2026, 17:55.

Change

Previous filing in this sequence was filed on 10 Jun 2026.
Current net transaction value: -$197,318.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001852291 Primary reporting owner

Wang Lai

Relationship: President, Global Head of R&D
Address: C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, SWITZERLAND
Signature: /s/ Qing Nian, as Attorney-in-Fact
Signature date: 15 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ONC transaction

Ordinary Shares

Award

Transaction value
Shares: +118,625
Change %: +7.5%
Price: $0.000000^*
Shares after: 1,710,085
Date: 11 Jun 2026
Ownership: Direct
Footnotes: F1

ONC transaction

American Depositary Shares

Sale

Transaction value: $197,318
Shares: -756
Change %: -100%
Price: $261.00
Shares after: 0
Date: 11 Jun 2026
Ownership: Direct
Footnotes: F6, F7, F8

ONC holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 601,965
Date: 11 Jun 2026
Ownership: See Footnote
Footnotes: F2

ONC holding

RMB Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 0
Date: 11 Jun 2026
Ownership: See Footnote
Footnotes: F3, F4, F5

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ONC transaction Derivative

Share Option (Right to Buy)

Award

Transaction value
Shares: +229,775
Change %
Price: $0.000000^*
Shares after: 229,775
Date: 11 Jun 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 229,775
Exercise price: $20.81
Footnotes: F9, F10

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 10 footnotes

Footnote F1

Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 11, 2026, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Footnote F2

These securities are held by Wang Holdings LLC, the limited liability company interests of which are owned by the Reporting Person, his spouse and a trust created by the Reporting Person for the benefit of his spouse and children, for which the Reporting Person disclaims beneficial ownership.

Footnote F3

The term "RMB Shares" is used herein to represent the ordinary shares, par value $0.0001 per share, of the Issuer, issued directly by the Issuer in the Issuer's initial public offering on the Science and Technology Innovation Board (the "STAR Market") of the Shanghai Stock Exchange (the "STAR Offering"), to permitted investors in Renminbi ("RMB") within the People's Republic of China ("PRC") in accordance with the rules of the STAR Market.

Footnote F4

The Issuer established an employee participation program ("RMB Shares Employee Participation Plan"), which allows certain executive officers and qualified employees of the Issuer's subsidiaries in the PRC to indirectly participate in the STAR Offering and purchase certain RMB Shares from the Issuer through an asset management plan administrated by China International Capital Corporation Limited in a transaction that is exempt under Rule 16b-3. The RMB Share Employee Participation Plan purchased an aggregate of 2,069,546 RMB Shares directly from the Issuer in the STAR Offering at the initial public offering price of RMB192.6 per RMB Share (or $30.1295 based on an assumed exchange rate of $1.00 = RMB6.3924).

Footnote F5

The Reporting Person, as an individual participant in the RMB Shares Employee Participation Plan, has contributed RMB10 million to the RMB Shares Employee Participation Plan. The Reporting Person may be deemed to have indirect economic interest in an indeterminable portion of the RMB Shares held by the RMB Shares Employee Participation Plan but does not have voting or dispositive power over any of such shares. The Reporting Person disclaims Section 16 beneficial ownership of the RMB Shares held by the RMB Shares Employee Participation Plan, except to the extent, if any, of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such RMB Shares for Section 16 or any other purpose.

Footnote F6

Each American Depositary Share represents 13 Ordinary Shares.

Footnote F7

The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 10, 2025, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Footnote F8

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $260.87 to $261.16, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Footnote F9

The number of securities underlying each option and the exercise price therefor are represented in ordinary shares.

Footnote F10

These securities vest over a four-year period as follows: 25% on the first anniversary of June 11, 2026 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.